Generics - Patents & Trade marks

Filter

Current filters:

Patents & Trade marks

Popular Filters

Herceptin patents ruled invalid by UK High Court leaving Hospira to launch generic

Herceptin patents ruled invalid by UK High Court leaving Hospira to launch generic

11-04-2014

The UK’s High Court has ruled that two patents on Swiss drug major Roche’s breast cancer drug Herceptin…

GenericsHealth Medical PharmaHealth Medical PharmaHerceptinHigh CourtHospiraLegalMylanOncologyPatents & Trade marksPharmaceuticalRocheTrastuzumabUK

Natco prevails in Indian Copaxone patent dispute with Teva

Natco prevails in Indian Copaxone patent dispute with Teva

03-03-2014

Hyderabad, India-based Natco Pharma has won a significant patent battle against Israeli generics giant…

Asia-PacificCopaxoneGenericsIndiaNatco PharmaPatents & Trade marksTeva Pharmaceutical Industries

Actavis challenges Multaq and Colcrys patents

02-03-2014

Ireland-headquartered generic drugmaker Actavis revealed on Friday (February 28) that French pharma giant…

ActavisAnti-Arthritics/RheumaticsCardio-vascularColcrysGenericsLegalMultaqNorth AmericaPatents & Trade marksRegulationSanofiTakeda PharmaceuticalsUSA

MSF warns of impact of proposed EU trade mark infringement measures

24-02-2014

Ahead of a vote tomorrow in the European Parliament on proposed strengthened EU enforcement of European…

EuropeGenericsPatents & Trade marks

Company Spotlight

ImmunoGen

ImmunoGen

Back to top